Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

AT-Grow, a natural product, might help with a common type of hair loss by reducing DHT levels.

Higher DHT in male baldness may protect against prostate cancer.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Finasteride effectively treats BPH, but needs more trials to understand potential.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Too much androgen can cause hair loss; finasteride may help.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Androgens prevent hair growth by changing Wnt signals in cells.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Finasteride may improve prostate cancer treatment outcomes.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Antiandrogen therapy helps treat genetic hair loss.